Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment

Clinical Chemistry

Volumn 43, Issue 9, 1997, Pages 1622-1629

  Nauck, Matthias ^a,h   März, Winfried ^b   Jarausch, Jochen ^c   Cobbaert, Christa ^d   Sägers, Anja ^e   Bernard, Dirk ^f   Delanghe, Joris ^g   Honauer, Gunter ^a   Lehmann, Paul ^a   Oestrich, Evelyn ^a   Von Eckardstein, Arnold ^b   Walch, Stephan ^a   Wieland, Heinrich ^a   Assmann, Gerd ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e GHENT UNIVERSITY   (Belgium)

^f Kreiskrankenhaus Bruchsal   (Germany)

^g Gemeinschaftspraxis Heidelberg   (Germany)

^h UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; DIAGNOSTIC ACCURACY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 9844246438     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.9.1622     Document Type: Article

References (28)

1. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J 1994;308:367-72.
2. Kannel WB, Castelli WP, Gordon T. Serum cholesterol, lipoproteins and the risk of coronary heart disease: the Framingham Study. Ann Intern Med 1971;74:1-12.
3. Lipid Research Clinics Program. The Lipid Research Clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984:251:365-74.
4. Yaari S, Goldbourt U, Even-Zohar S, Neufeld HN. Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular and cancer mortality in a 7-year prospective study of 10000 men. Lancet 1981;1:1011-5.
5. Keys A. High density lipoprotein cholesterol and longevity. J Epidemiol Community Health 1988;42:60-5.
6. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988;8:737-41.
7. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994; 89:1330-445.
8. International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society. Nutr Metab Cardiovasc Dis 1992;2:113-56.
9. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic artery disease (the PROCAM experience). Am J Cardiol 1992;70:733-7.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
11. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-4.
12. Warnick GR, Cheung MC, Albers JJ. Comparison of current methods for high-density lipoprotein cholesterol quantification. Clin Chem 1979:25:596-604.
13. Demacker PNM, Vos-Janssen HE, Hijmans AGM, van't Laar A, Janssen AP. Measurement of high-density lipoprotein cholesterol in serum: comparison of six isolation methods with enzymatic cholesterol analysis. Clin Chem 1980;26:1780-6.
14. Warnick GR, Albers JJ, Leary ET. HDL cholesterol: results of interlaboratory proficiency tests [Letter]. Clin Chem 1980;26: 169-70.
15. Warnick GR, Wood PD for the National Cholesterol Education Program Working Group on Lipoprotein Measurement. National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. Clin Chem 1995;41:1427-33.
16. Sugiuchi H, Yoshinori U, Okabe H, Irie T, Uekama K, Kayahara N, Miyauchi K. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and α-cyclodextrin. Clin Chem 1995;41:717-23.
17. Nauck M, März W, Haas B, Wieland H. Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated. Clin Chem 1996:42:424-9.
18. Harris N, Galpachian V, Rifai N. Three routine methods for measuring high-density lipoprotein cholesterol compared with the reference method. Clin Chem 1996;42:738-43.
19. Manual of laboratory operation. Lipid Reserch Clinics Program. DHEW No (NIH) 75-628. Bethesda, MD: National Heart and Lung Institute, 1974:1-74.
20. Wanner C, Hörl WH, Luley C, Wieland H. Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. Kidney Int 1991:39:754-9.
21. Vanderline RE, Bowers GN Jr, Schaffer R, Edwards GC. The National Reference System for Cholesterol. Clin Lab Med 1989; 9:89-104.
22. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human plasma. J Clin Invest 1955;34:1345-53.
23. Glick MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986;32:470-5.
24. Passing H, Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample size. Part II. J Clin Chem Clin Biochem 1984;22:431-45.
25. NCCLS. Tentative guidline EP5-T. User evaluation of precision performance of clinical chemistry devices. Villanova, PA: National Committee for Clinical Laboratory Standards, June 1984.
26. 2 precipitation and a quantitative lipoprotein electrophoresis assay. Clin Chim Acta 1986;160:1-18.
27. Nauck M, Friedrich l, Wieland H. Measurement of LDL and VLDL cholesterol with precipitation techniques. A comparison with the ultracentrifugation method. Klin Lab 1994;40:167-76.
28. Wieland H, Seidel D. Improved assessment of plasma lipoprotein patterns. IV. Simple preparation of a lyophilized control serum containing intact human plasma lipoproteins. Clin Chem 1982; 28:1335-7.